Press releases
Latest news
May 19, 2023
Ultragenyx to Present at the 2023 Barclays - Gene Editing & Gene Therapy Summit
Read more
May 17, 2023
Ultragenyx Receives FDA Agreement to Expand Ongoing Global Phase 1/2 Trial Evaluating GTX-102 in Patients with Angelman Syndrome in the U.S.
Read more
May 08, 2023
Ultragenyx Announces Upcoming Data Presentations at American Society of Gene & Cell Therapy (ASGCT) 2023 Annual Meeting
Read more
April 27, 2023
Ultragenyx to Host Conference Call for First Quarter 2023 Financial Results and Corporate Update
Read more
March 28, 2023
Ultragenyx to Present at Guggenheim’s Genomic Medicines and Rare Disease Days
Read more
Displaying 1 - 10 of 10